CRLF2 overexpression has been reported as a major feature in the Philadelphia chromosome (Ph)-like subtype of B-cell acute lymphoblastic leukemia(B-ALL), and approximately 50-60% of patients with Ph-like B-ALL have CRLF2 overexpression (1–4). Here, CRLF2 is linked to acute lymphoblastic leukemia.